Renal disease in small-vessel vasculitis

Area of Science:

• Nephrology
• Rheumatology
• Immunology

Background:

• Glomerulonephritis (GN) is a common manifestation of antineutrophil cytoplasmic antibody-associated systemic vasculitides (AASV).
• Renal involvement in AASV significantly impacts patient survival and prognosis.
• Older patients with AASV-related renal vasculitis often present with more severe disease.

Purpose of the Study:

• To highlight the significance of early renal involvement assessment in AASV.
• To discuss diagnostic and prognostic implications of renal biopsy in AASV.
• To review current treatment strategies and outcomes for AASV patients with renal complications.

Main Methods:

• Review of clinical data and outcomes for AASV patients with varying degrees of renal involvement.
• Analysis of prognostic factors including renal function at diagnosis and presence of urinary sediment.
• Evaluation of treatment efficacy for cyclophosphamide and plasma exchange in inducing remission and promoting renal recovery.

Main Results:

• Renal involvement, even with normal function but urinary sediment, doubles mortality risk in AASV patients.
• Impaired renal function at diagnosis increases mortality risk fivefold.
• Renal failure affects 25% of AASV patients within 3-4 years, with 60% recovering function after dialysis.
• Renal vasculitis is an independent risk factor for cardiovascular events.

Conclusions:

• Early assessment of renal involvement is critical for survival in AASV patients.
• Renal biopsy provides essential diagnostic and prognostic information.
• While renal failure is a risk, recovery is possible, and renal transplant outcomes are comparable.
• Managing renal vasculitis is key to improving overall prognosis and reducing cardiovascular risk in AASV.